looking for aus pharmaceuticals to invest in, page-43

  1. 19,134 Posts.
    lightbulb Created with Sketch. 181
    Biota has just got approval in Japan for Laninamivir. This the main product to replace Relenza as patents expire over the next 4-9 years.

    Hoping a ROW licensing deal can now be done for the product at a good price.

    I hold.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.